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Abstract: N-Acetylhexosamine 1-kinase (NahK) catalyzes the direct addition of a 
phosphate from adenosine 5'-triphosphate (ATP) to the anomeric position of  
N-acetylhexosamine and shows similar activity towards N-acetylglucosamine (GlcNAc) 
and N-acetylgalactosamine (GalNAc). Herein we report the cloning, characterization, and 
substrate specificity studies of two NahKs from Bifidobacterium infantis ATCC15697 and 
Bifidobacterium longum ATCC55813, respectively. A new capillary electrophoresis assay 
method has been developed for enzyme activity assays. Both enzymes have a good 
expression level in E. coli (180–185 mg/L culture) and can tolerate diverse modifications 
at C2 of GlcNAc and GalNAc. Various GlcNAc derivatives with C6, both C2 and C6, as 
well as both C2 and C3 modifications are tolerable substrates for the newly cloned NahKs. 
Quite interestingly, despite of their low activities toward glucose and galactose, the activities 
of both NahKs are much higher for mannose and some of its C2, C4, and C6 derivatives. These 
NahKs are excellent catalysts for enzymatic and chemoenzymatic synthesis of carbohydrates. 
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1. Introduction 
N-Acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) are important mono-
saccharides broadly distributed in Nature. GlcNAc plays an important role in plant organogenesis and 
invertebrate embryogenesis [1]. It is an essential component of protein N-glycans and some important 
polysaccharides including chitin (the second most abundant carbohydrate after cellulose) [2,3], bacterial 
cell wall [4], and some glycosaminoglycans such as hyaluronic acid, keratan sulfate, and heparan 
sulfate/heparin [5-7]. It also exists in many O-glycans. In addition, glycoproteins modified with  
O-GlcNAc monosaccharide have been increasingly identified [8,9]. In comparison, GalNAc is an 
essential component of protein O-glycans and some glycosaminoglycans such as chondroitin sulfate 
and dermatan sulfate [5]. It also exists in many gangliosides. Therefore, it is in an urgent need to 
develop high efficient processes for producing GlcNAc and GalNAc-containing carbohydrates and 
glycoconjugates. 
In Nature, the biosynthesis of GlcNAc and GalNAc-containing oligosaccharides and 
glycoconjugates is carried out by corresponding glycosyltransferases which require sugar nucleotide 
donors such as uridine 5'-diphospho-GlcNAc (UDP-GlcNAc) and uridine 5'-diphospho-GalNAc 
(UDP-GalNAc). For in vitro enzymatic synthesis of these compounds, in situ generation of sugar 
nucleotides is a common practice to reduce the synthetic cost. The simplest route for enzymatic 
synthesis of both UDP-N-acetylhexosamines (UDP-HexNAc) and their derivatives is the combined use 
of an N-acetylhexosamine 1-kinase (NahK) [10-12] and an N-acetylglucosamine-1-phophate 
uridyltransferase (GlmU [13,14] or AGX1 [15]). 
NahK (EC 2.7.1.162) catalyzes the direct addition of a phosphate from adenosine 5'-triphophate 
(ATP) to the anomeric position of N-acetylhexosamine for the formation of N-acetylhexosamine-1-
phosphate and adenosine 5'-diphophate (ADP). The only characterized NahK to date is encoded by the 
lnpB gene in the lnpABCD operon of Bifidobacterium longum JCM1217 [10]. Herein we report the 
cloning and characterization of two new NahKs from Bifidobacterium infantis (ATCC15697) and 
Bifidobacterium longum (ATCC55813), respectively. A new capillary electrophoresis-based assay 
method has been developed for biochemical characterization of NahKs. We found that in addition to 
previously reported NahK substrates, various GlcNAc derivatives including those with C2-azido,  
C6-azido, and 6-O-sulfate groups are tolerable substrates for the newly cloned NahKs. In addition, 
despite of their low activities toward glucose and galactose, the activities of both NahKs are much 
higher for mannose and some of its C2, C4, and C6 derivatives including 2-deoxymannose or  
2-deoxyglucose. 
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2. Results and Discussion 
2.1. Cloning, Expression, and Purification 
NahKs from Bifidobacterium infantis ATCC#15697 (NahK_ATCC15697) and Bifidobacterium 
longum ATCC#55813 (NahK_ATCC55813) were each cloned as a C-His6-tagged fusion protein in a 
pET22b(+) vector. Sequence alignment (Figure 1) indicates that NahK_ATCC55813 is almost 
identical to the NahK from Bifidobacterium longum JCM1217 (NahK_JCM1217, GenBank accession 
no. BAF73925) except for a single amino acid difference R348H (R is in NahK_JCM1217).  
In comparison, NahK_ATCC15697 shares 90% amino acid sequence identity with NahK_JCM1217. 
Figure 1. Sequence alignment of NahK_JCM1217 (GenBank accession no. BAF73925), 
NahK_ATCC55813, and NahK_ATCC15697. 
 
Both NahKs were expressed by induction with 0.1 mM of isopropyl-1-thio-β-D-galactopyranoside 
(IPTG) followed by incubation at 20 °C for 24 h with vigorous shaking (250 rpm). Up to 180 mg and 
185 mg of Ni2+-column purified NahK_ATCC15697 and NahK_ATCC55813, respectively, could be 
obtained from one liter of E. coli culture. SDS-PAGE analysis (Figure 2) shows that both purified 
proteins migrated to around 41 kDa, matching well to the calculated molecular weights of  
the translated His6-tagged fusion proteins of 41.4 and 40.9 kDa for NahK_ATCC15697 and 
NahK_ATCC55813, respectively. 
2.2. Capillary Electrophoresis (CE) Assays 
Based on the detection of ADP and ATP in the reaction mixture by a UV detector, a capillary 
electrophoresis-based method was developed to directly measure the formation of ADP and  
N-acetylhexosamine-1-phosphate from ATP and N-acetylhexosamine for characterizing the activities 
of NahKs. Both ATP and ADP gave absorbance at 254 nm with equal signal responses. 
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2.4. Effect of MgCl2 
Similar to NahK_JCM1217 [10] and other kinases, both NahK_ATCC15697 and NahK_ATCC55813 
require a divalent metal ion for activity. As shown in Figure 4, the optimal concentration of Mg2+ was 
determined to be 1 mM. The activities of both NahKs in the presence of 0.5 mM of Mg2+ were about 
two thirds of those in the presence of 1.0 mM of Mg2+. Increasing the concentration of Mg2+ from  
1 mM to 20 mM caused a slight decrease of the activities of both NahKs. 
Figure 4. The effect of MgCl2 on the activities of NahKs. 
 
2.5. Kinetics 
The apparent kinetic parameters shown in Table 1 indicate that the activities of two NahKs are 
close, with NahK_ATCC55813 having 16% or 39% higher activity than NahK_ATCC15697 when 
GlcNAc or GalNAc was used as the substrate in the presence of ATP. Overall, GlcNAc is a more 
efficient (3.1-fold for NahK_ATCC15697 and 2.6-fold for NahK_ATCC55813) substrate than GalNAc 
for both NahKs due to relatively lower Km values and higher (~2-fold) kcat values obtained when GlcNAc 
was used. Using ATP and GlcNAc as the substrates, the Km values of ATP (0.10 ± 0.03 mM and  
0.11 ± 0.03 mM) and GlcNAc (0.06 ± 0.01 mM) for both NahKs are lower than those for 
NahK_JCM1217 (0.172 mM for ATP and 0.118 mM for GlcNAc) determined by high performance 
ion chromatography (HPIC) with a pulsed amperometric detector (DX500, Dionex Corporation, 
Sunnyvale, CA, USA) using a Dionex CarboPac PA1 column (4 mm × 250 mm) [10]. The 
discrepancies of the parameters may be due to the differences in the assay conditions used. 
Table 1. Apparent kinetic parameters of NahKs. 
Enzymes NahK1_ATCC15697 NahK_ATCC55813 
Substrate Km (mM) kcat (s−1) kcat/Km (s−1 mM−1) Km (mM) kcat (s−1) kcat/Km (s−1 mM−1) 
ATP a  0.10 ± 0.03 1.1 ± 0.1 11.0 0.11 ± 0.03 1.3 ± 0.1 11.8 
GlcNAc 0.06 ± 0.01 0.95 ± 0.01 15.8 0.06 ± 0.01 1.1 ± 0.1 18.3 
ATP b 0.08 ± 0.03 0.38 ± 0.02 4.8 0.06 ± 0.02 0.48 ± 0.03 8.0 
GalNAc 0.09 ± 0.05 0.46 ± 0.07 5.1 0.08 ± 0.03 0.57 ± 0.04 7.1 
a The other substrate is GlcNAc; b The other substrate is GalNAc. 
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2.6. Substrate Specificity 
The substrate specificity studies using GlcNAc, GalNAc, and their derivatives (Table 2) indicate 
that both NahKs exhibit promiscuous substrate specificity and have comparable levels of activity 
toward GlcNAc and GalNAc derivatives. Compared to NahK_ATCC15697, NahK_ATCC55813 is 
more reactive towards non-modified GlcNAc (1), GalNAc (11), and some of their C2-modified 
derivatives with an N-trifluoroacetyl (GlcNTFA 2 and GalNTFA 12), an N-azidoacetyl group 
(GlcNAcN3 3 and GalNAcN3 13), or an N-butanoyl group (GlcNBu 4 and GalNBu 14). Nevertheless, 
NahK_ATCC15697 is more reactive than NahK_ATCC55813 for some of C2-modified GlcNAc and 
GalNAc derivatives such as those with a bulky N-benzoyl group (GlcNBz 5 and GalNBz 15) and a  
C2-azido group (GlcN3 6 and GalN3 16). NahK_ATCC15697 is also more reactive towards 2-amino-2-
deoxy-glucose (GlcNH2 7), 2-N-sulfo-glucose (GlcNS 8), as well as C6-modified GlcNAc derivatives 
such as 6-deoxy-GlcNAc (GlcNAc6Me 9), 6-azido-6-deoxy-GlcNAc (GlcNAc6N3 10), and 6-O-sulfo-
GlcNAc (GlcNAc6S 17). Both C2 and C6-modified derivatives GlcNAc such as 6-O-sulfo-N-
trifluoroacetyl glucosamine (GlcNTFA6S 18) and 6-O-sulfo-2-azido-2-deoxy glucose (GlcN3 19) as 
well as both C2 and C3-modified GlcNAc derivative 3-O-sulfo-2-azido-2-deoxy glucose (GlcN33S 20) 
are poor but acceptable substrates for both enzymes. Overall, some of the C2-modified GlcNAc and 
GalNAc (1–5 and 11–14) are relatively good substrates for both NahKs with yields varied from  
5.2%–42.3% in a 10 min reaction containing 0.75 μM of enzyme. In comparison, other C2-modified 
GlcNAc and GalNAc (6–8, 15, 16), C6- (9, 10, 17), both C2- and C6- (18, 19), as well as both C2- and 
C3-modified GlcNAc (20) derivatives are poor but tolerable substrates for both NahKs and the assays 
have to be carried out for a longer reaction time (30 min) with a 20-fold higher concentration (15 μM)  
of enzyme. 
Among twenty compounds of GlcNAc, GalNAc and their derivatives tested, compounds 1, 3–5, 9–11, 
13–15 have been reported before as suitable substrates for NahK_JCM1217 [11,12], while other 
compounds including 2, 6–8, 12, and 16–20 are newly identified substrates for NahKs. It is worth to 
note that some of these compounds have negatively charged O-sulfate group at different positions of 
GlcNAc or its derivatives. 
Quite interestingly, the substrate specificity studies using glucose (Glc 21), galactose (Gal 28), 
mannose (Man 23), N-acetylmannosamine (ManNAc 29), and derivatives of mannose and ManNAc 
(Table 3) indicate that while both Glc (21) and Gal (28) are poor substrates for both NahKs, 2-deoxy 
glucose (2-deoxyGlc 22) or 2-deoxymannose is a better substrate. In addition, mannose (23), its  
2-fluoro- (2F-Man 24) and 2-azido- (2N3-Man 26) derivatives, as well as its 4-deoxy (4-deoxyMan 27) 
derivative are relatively good substrates. In comparison, 2-methyl modification of mannose (2Me-Man 25) 
decreases its tolerance as the substrate for both NahKs. Quite surprisingly, while ManNAc (29) and 
some of its C2 derivatives (30–32) are poor substrates for the NahKs, N-azidoacetylmannosamine 
(ManNAcN3 33, a C2-derivative of ManNAc) and its C6-derivative N-acetyl-6-O-methylmannosamine 
(ManNAc6OMe 34) are better substrates for both NahKs. Overall, except for 2-fluoro-mannose  
(2F-Man 24), NahK_ATCC15697 shows higher activity than NahK_ATCC55813 for mannose, 
ManNAc, and their derivatives. 
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Table 2. Substrate specificity of NahKs using GlcNAc, GalNAc, and their derivatives. 
Substrates 
Percentage Conversion (%) 
Substrates 
Percentage Conversion (%) 
NahK_ATCC15697 NahK_ATCC55813 NahK_ATCC15697 NahK_ATCC55813
a 0.75 μM b 15 μM a 0.75 μM b 15 μM a 0.75 μM b 15 μM a 0.75 μM b 15 μM 
 
1 GlcNAc 
35.4 ± 0.1 NA 42.3 ± 0.2 NA  
11 GalNAc 
12.5 ± 0.1 NA 19.9 ± 0.1 NA 
 
2 GlcNTFA 
10.7 ± 0.9 NA 16.2 ± 0.9 NA 
 
12 GalNTFA 
11.2 ± 1.6 NA 21.8 ± 0.2 NA 
 
3 GlcNAcN3 
11.5 ± 1.0 NA 22.8 ± 0.4 NA 
 
13 GalNAcN3 
9.9 ± 0.6 NA 21.0 ± 1.2 NA 
 
4 GlcNBu 
20.9 ± 0.6 NA 35.0 ± 2.0 NA  
14 GalNBu 
12.1 ± 0.3 NA 24.0 ± 0.1 NA 
 
5 GlcNBz 
10.3 ± 0.4 NA 5.2 ± 0.2 NA 
 
15 GalNBz 
0 62.2 ± 1.0 0 51.9 ± 0.5
 
6 GlcN3 
0 14.5 ± 0.1 0 7.0 ± 0.1  
16 GalN3 
0 7.6 ± 0.1 0 4.3 ± 0.1
 
7 GlcNH2 
0 15.0 ± 0.1 0 8.4 ± 0.1
17 GlcNAc6S 
0 11.7 ± 0.2 0 6.6 ± 0.1
 
8 GlcNS 
0 6.4 ± 0.2 0 4.0 ± 0.1
 
18 GlcNTFA6S
0 7.2 ± 0.1 0 3.3 ± 0.2
 
9 GlcNAc6Me 
4.4 ± 1.2 41.8 ± 0.3 2.1 ± 0.2 36.3 ± 0.3
19 GlcN36S 
0 6.9 ± 0.1 0 4.4 ± 0.1
 
10 GlcNAc6N3
0 37.2 ± 0.5 0 23.4 ± 0.1
20 GlcN33S 
0 4.9 ± 0.1 0 3.9 ± 0.1
NA: not assayed; a Reactions were allowed to proceed for 10 min at 37 °C; b Reactions were 
allowed to proceed for 30 min at 37 °C. 
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Table 3. Substrate specificity of NahKs using Glc, Gal, Man, ManNAc, and their derivatives. 
Substrates 
Percentage Conversion (%) 
Substrates 
Percentage Conversion (%) 
NahK_ATCC15697 NahK_ATCC55813 NahK_ATCC15697 NahK_ATCC55813
21 Glc 
9.1 ± 0.1 4.7 ± 0.1  
28 Gal 
7.3 ± 0.2 4.4 ± 0.1 
22  
2-deoxyGlc 
44.8 ± 0.2 28.4 ± 0.1 
29 ManNAc 
8.9 ± 0.1 5.5 ± 0.1 
23 Man 
68.0 ± 1.7 37.1 ± 0.4 
30 ManNGc 
7.6 ± 0.1 5.4 ± 0.2 
24 2F-Man 
44.4 ± 0.2 47.0 ± 0.1 
31 ManNAcF 
12.0 ± 0.1 9.1 ± 0.2 
25  
2Me-Man 
9.4 ± 0.5 0 
32 
ManNAcOMe 
12.0 ± 0.4 7.4 ± 0.3 
26 2N3-Man 
53.3 ± 0.1 40.2 ± 0.2 
33 ManNAcN3 
20.3 ± 0.3 18.6 ± 0.4 
27  
4-deoxyMan 
37.1 ± 0.2 23.9 ± 0.1 
34 
ManNAc6OMe 
32.6 ± 0.1 28.9 ± 0.1 
The concentration of the enzyme used was 15 μM. Reactions were allowed to proceed for 30 min at 37 °C. 
3. Experimental 
3.1. Bacterial Strains, Plasmids, and Materials 
Electrocompetent DH5α and chemically competent BL21 (DE3) E. coli cells were from Invitrogen 
(Carlsbad, CA). Bifidobacterium longum Reuter ATCC#55813 was from American Type Culture 
Collection (ATCC, Manassas, VA, USA). Genomic DNA of Bifidobacterium longum subsp. infantis 
(ATCC#15697) was a kind gift from Professor David Mills (University of California, Davis). Vector 
plasmid pET22b(+) was from Novagen (EMD Biosciences Inc. Madison, WI, USA). Ni2+-NTA 
agarose (nickel–nitrilotriacetic acid agarose), QIAprep spin miniprep kit, and QIAEX II gel extraction 
kit were from Qiagen (Valencia, CA, USA). Herculase-enhanced DNA polymerase was from 
Stratagene (La Jolla, CA). T4 DNA ligase and 1 kb DNA ladder were from Promega (Madison, WI, 
USA). NdeI and XhoI restriction enzymes were from New England Biolabs Inc. (Beverly, MA, USA). 
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Adenosine-5'-triphosphate disodium salt (ATP), GlcNAc, and GalNAc were from Sigma (St. Louis, 
MO, USA). GlcNAc, GalNAc, mannose, and ManNAc derivatives were synthesized according to 
reported procedures [11,12,16-20]. 
3.2. Cloning 
NahK_ATCC15697 and NahK_ATCC55813 were each cloned as a C-His6-tagged fusion protein in 
pET22b(+) vector using genomic DNAs of Bifidobacterium longum subsp. infantis ATCC#15697 and 
Bifidobacterium longum ATCC#55813, respectively, as the template for polymerase chain reactions 
(PCR). The primers used for NahK_ATCC15697 were: Forward primer 5' ACCCCATATGAACAAC 
ACCAATGAAGCCCTG 3' (NdeI restriction site is underlined) and reverse primer 5' TGAC 
CTCGAGCTTGGTCGTCTCCATGACGTCG 3' (XhoI restriction site is underlined). The primers 
used for NahK_ATCC55813 were: Forward primer 5' ACCCCATATGACCGAAAGCAATGAAGTTT 
TATTC 3' (NdeI restriction site is underlined) and reverse primer 5' TGACCTCGAGCCTGGCAGC 
CTCCATGATG 3' (XhoI restriction site is underlined). PCR was performed in a 50 μL reaction 
mixture containing genomic DNA (1 μg), forward and reverse primers (1 μM each), 10 × Herculase 
buffer (5 μL), dNTP mixture (1 mM), and 5 U (1 μL) of Herculase-enhanced DNA polymerase. The 
reaction mixture was subjected to 35 cycles of amplification with an annealing temperature of 52 °C. 
The resulting PCR product was purified and digested with NdeI and XhoI restriction enzymes. The 
purified and digested PCR product was ligated with predigested pET22b(+) vector and transformed 
into electrocompetent E. coli DH5α cells. Selected clones were grown for minipreps and 
characterization by restriction mapping and DNA sequencing performed by Davis Sequencing Facility 
at the University of California-Davis. 
3.3. Expression and Purification 
Positive plasmids were selected and transformed into BL21(DE3) chemically competent cells. The 
plasmid-bearing E. coli cells were cultured in LB rich medium (10 g/L tryptone, 5 g/L yeast extract, 
and 10 g/L NaCl) supplied with ampicillin (100 μg/mL). Overexpression of the target protein was 
achieved by inducing the E. coli culture with 0.1 mM of isopropyl-1-thio-β-D-galactopyranoside 
(IPTG) when the OD600 nm of the culture reaches 0.8–1.0 followed by incubation at 20 °C for 24 h with 
vigorous shaking at 250 rpm in a C25KC incubator shaker (New Brunswick Scientific, Edison, NJ, 
USA). To obtain the cell lysate, cells were harvested by centrifuge cell culture at 4000 × g for 2 hrs. 
The cell pellet was re-suspended in lysis buffer (pH 8.0, 100 mM Tris-HCl containing 0.1% Triton  
X-100, 20 mL L−1 cell culture) containing lysozyme (100 μg/mL) and DNaseI (3 μg/mL). After 
incubating at 37 °C for 60 min with vigorous shaking (250 rpm), the lysate was collected by 
centrifugation at 12,000 g for 30 min. His6-tagged target proteins were purified from cell lysate using 
an ÄKTA FPLC system (GE Healthcare, Piscataway, NJ, USA). To do this, the lysate was loaded to a 
HisTrapTM FF 5 mL column (GE Healthcare) pre-washed and equilibrated with binding buffer (0.5 M 
NaCl, 20 mM Tris-HCl, pH 7.5). The column was then washed with 8 volumes of binding buffer,  
10 volumes of washing buffer (10 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.5) and eluted 
with 8 volumes of elute buffer (200 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.5). Fractions 
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containing the purified enzyme were combined and dialyzed against dialysis buffer (Tris-HCl 
containing 10% glycerol, pH 7.5, 20 mM) and stored at 4 °C. 
3.4. Quantification of Purified Protein 
Protein concentration was determined in a 96-well plate using a Bicinchoninic Acid (BCA) Protein 
Assay Kit (Pierce Biotechnology, Rockford, IL, USA) with bovine serum albumin as a protein 
standard. The absorbance of each sample was measured at 562 nm by a BioTek SynergyTM HT  
Multi-Mode Microplate Reader. 
3.5. pH Profile by Capillary Electrophoresis (CE) Assays 
Typical enzymatic assays were performed in a 20 μL reaction mixture containing a buffer (200 mM) 
with a pH in the range of 6.0–11.0, GlcNAc (1 mM), ATP (1 mM), MgCl2 (5 mM), and a NahK (0.75 μM). 
Buffers used were: MES, pH 6.0; Tris-HCl, pH 7.0–9.0; CAPS, pH 10.0–11.0. Reactions were allowed 
to proceed for 10 min at 37 °C and were stopped by adding 20 μL of cold ethanol to each reaction 
mixture. Samples were centrifuged and the supernatants were analyzed by a P/ACETM Capillary 
Electrophoresis (CE) system equipped with a Photodiode Array (PDA) detector (Beckman Coulter, 
Inc., Fullerton, CA, USA). CE conditions were as follows: 75 μm i.d. capillary, 25 KV/80 μÅ, 5 s vacuum 
injections, monitored at 254 nm, the running buffer used was sodium tetraborate (25 mM, pH 10.0). 
3.6. Effect of MgCl2 on the Enzymatic Activity 
Different concentrations of MgCl2 were used in a Tris-HCl buffer (pH 8.0, 200 mM) containing 
GlcNAc (1 mM), ATP (1 mM), and a NahK (0.75 μM). Reactions were allowed to proceed for 10 min 
at 37 °C. Reaction without MgCl2 was used as a control. 
3.7. Substrates Specificity Assays 
GlcNAc, GalNAc, and their derivatives (1 mM) were used as substrates in the presence of ATP  
(1 mM) and MgCl2 (5 mM) in a Tris-HCl buffer (pH 8.0, 200 mM) to analyze the substrate specificity 
of NahKs. Two concentrations (0.75 μM or 15 μM) of each NahK were used and the reactions were 
allowed to proceed for 10 min (for 0.75 μM NahK) or 30 min (for 15 μM NahK) at 37 °C. For 
substrate specificity studies of Glc, Gal, mannose, ManNAc, and their derivatives, 15 μM of NahK 
was used for each reaction and the reactions were carried out at 37 °C for 30 min. All other conditions 
were the same as for GlcNAc, GalNAc, and their derivatives. 
3.8. Kinetics by CE Assays 
Reactions were carried out in duplicate at 37 °C for 10 min in a total volume of 20 μL in Tris-HCl 
buffer (200 mM, pH 7.5) containing MgCl2 (1 mM), ATP, GlcNAc or GalNAc, and NahK (0.25 μM 
when GlcNAc and ATP were used as substrates, 0.5 μM when GalNAc and ATP were used as substrates). 
Apparent kinetic parameters were obtained by varying the ATP concentration from 0.1–5.0 mM (0.1 mM, 
0.2 mM, 0.4 mM, 1 mM, 2 mM, and 5 mM) at a fixed concentration of GlcNAc or GalNAc (1 mM), or 
varying the concentration of GlcNAc or GalNAc (0.1 mM, 0.2 mM, 0.4 mM, 1 mM, 2 mM, and  
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5 mM) at a fixed concentration of ATP (1 mM) and fitting the data to the Michaelis-Menten equation 
using Grafit 5.0. 
4. Conclusions 
In summary, two new N-acetylhexosamine 1-kinases, NahK_ATCC15697 and NahK_ATCC55813, 
were successfully cloned. Substrates specificity studies showed that both enzymes are promiscuous 
and can tolerate various modifications at C2 of GlcNAc and GalNAc. C6-, both C2- and C6-, and both 
C2- and C3-modified GlcNAc derivatives are also tolerable substrates for both newly cloned NahKs. 
In addition, both NahKs can use mannose and its C2, C4, and C6 derivatives as substrates. The high 
expression level (180–185 mg/L culture) and promiscuous substrate specificity of NahKs make them 
excellent catalysts for application in chemoenzymatic synthesis of carbohydrates. 
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